Suppr超能文献

小鼠实验性肝毛细线虫感染的药物治疗

Drug treatment of experimental Capillaria hepatica infection in mice.

作者信息

Cheetham R F, Markus M B

机构信息

Department of Zoology, University of Witwatersrand, Johannesburg, South Africa.

出版信息

Parasitol Res. 1991;77(6):517-20. doi: 10.1007/BF00928420.

Abstract

This report presents the results obtained using 14 anthelmintic compounds that were tested in experimental white mice of the Swiss-Webster strain for their action against Capilaria hepatica. Four of the drugs effectively prevented deposition of C. hepatica ova in mouse liver. The doses at which these four drugs prevented greater than 99% of egg deposition were: albendazole, 30 mg/kg; febantel, 30 mg/kg; mebendazole, 3.13 mg/kg; and oxfendazole, 12.5 mg/kg. Of these, mebendazole is the only agent for which the application of five daily doses of 3.13 mg/kg lay within the dose range recommended for man.

摘要

本报告介绍了使用14种抗蠕虫化合物在瑞士韦伯斯特品系实验小白鼠中测试其对肝毛细线虫作用所获得的结果。其中四种药物有效防止了肝毛细线虫虫卵在小鼠肝脏中的沉积。这四种药物防止超过99%的虫卵沉积的剂量分别为:阿苯达唑,30毫克/千克;非班太尔,30毫克/千克;甲苯达唑,3.13毫克/千克;奥芬达唑,12.5毫克/千克。其中,甲苯达唑是唯一一种每日五次服用3.13毫克/千克的剂量在推荐给人类的剂量范围内的药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验